home / stock / huge / huge news


HUGE News and Press, FSD Pharma Inc. From 01/22/21

Stock Information

Company Name: FSD Pharma Inc.
Stock Symbol: HUGE
Market: NASDAQ
Website: fsdpharma.com

Menu

HUGE HUGE Quote HUGE Short HUGE News HUGE Articles HUGE Message Board
Get HUGE Alerts

News, Short Squeeze, Breakout and More Instantly...

HUGE - FSD Pharma Sets Date for Annual Meeting

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on June 29, 2021. The Meeting will address normal course matters, including the pre...

HUGE - The Top 11 Most Profitable Cannabis Stocks, And The Ones To Watch

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

HUGE - Cannabis Goes Green With Blue Victory, U.S. Stocks Will Soar

Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...

HUGE - Cannabis Stocks: Outlook For 2021 And What To Look For

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

HUGE - Dosing underway in FSD Pharma's mid-stage FSD201 study in COVID-19

FSD Pharma (HUGE) has dosed the the first patient in its Phase 2a clinical trial of FSD201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) for the treatment of hospitalized patients with COVID-19. The primary objective of trial is to determine whether FSD201 plus standard...

HUGE - FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19

-----FDA has authorized randomized, controlled, double-blind study on 352 patients. The Company is expected to conduct this trial in 25-30 Medical Centers and Hospitals in North America FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Com...

HUGE - Zoom Video Communications, CureVac leads premarket losers' pack

Titan Pharmaceuticals (TTNP) -15%.Tuniu TOUR -15% on Q3 earnings release.Medigus MDGS -15% on appointment of new finance chief at MedigusECMOHO MOHO -14% on Q3 earnings release.Minerva Neurosciences (NERV) -14% after announcing outcome of Type C meeting with...

HUGE - NKLA, KNDI, APPN and HYLN among midday movers

Gainers: China Automotive Systems (CAAS) +77%.Sundial Growers (SNDL) +63%.Veritone (VERI) +47%.AquaBounty Technologies (AQB) +42%.Marathon Patent Group (MARA) +34%.FSD Pharma (HUGE) +33%.Apollo Endosurgery (APEN) +28%.India Globalization Capital (IGC) +25%.Codiak BioSciences (CDAK) +24%.Riot ...

HUGE - Sundial Growers, FSD Pharma leads healthcare gainers; SCWorx, 9 Meters Biopharma among major losers

Gainers: Sundial Growers (SNDL) +35%, FSD Pharma (HUGE) +32%, Apollo Endosurgery (APEN) +26%, G1 Therapeutics (GTHX) +23%, Oncolytics Biotech (ONCY) +17%.Losers: SCWorx (WORX) -14%, 9 Meters Biopharma (NMTR) -14%, AnPac Bio-Medical Science (ANPC)&#...

HUGE - MRNA, GME, GNW and QS among premarket gainers

Sunesis Pharmaceuticals (SNSS) +50% after announcing merger agreement with Viracta Therapeutics.China Automotive Systems (CAAS) +32% on guiding 2021 sales boom.India Globalization Capital (IGC) +24%.Ameri Holdings (AMRH) +26%.Oramed Pharmaceuticals (ORMP) +24%.Navios ...

Previous 10 Next 10